((自动化翻译由路透提供，请见免责声明 )) (增加股份出售细节)
路透9月30日 - 辉瑞 的一家账簿管理人周一表示，辉瑞打算出售英国消费者保健公司Haleon 的约5.4亿股股份，从而将第一大股东在这家感舒洁生产商中的权益降至16.2%。
Haleon周一还表示，它已同意从辉瑞公司购买价值约2.3亿英镑(，价值3.0818亿美元) 的普通股。
今年3月，这家美国制药巨头出售了价值约35亿美元的Haleon股份，这是自2022年Panadol和Advil止痛药生产商从葛兰素史克 分拆并在伦敦证券交易所上市以来的首次此类出售。
辉瑞去年曾表示，计划在几个月内以 "缓慢而有条不紊 "的方式减持公司股份。
葛兰素史克今年 5 月通过出售其在 Haleon 的剩余股份筹集了 (link) 12.5 亿英镑，Haleon 是 2019 年由葛兰素史克和辉瑞的消费者保健业务合并而成的。
(1美元=0.7463英镑)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.